Åsmund Flobak

Åsmund Flobak is an Associate Professor at the Norwegian University of Science and Technology, where he leads the FlobakLab and serves as Principal Investigator for the IMPRESS-Norway clinical trial. His research integrates wet-lab experiments and computational modeling to predict drug responses in cancer.

Education includes:

• Medical Doctor (2005)
• MSc Nanotechnology (2013)
• PhD in Systems Medicine (2016)

His research focuses on systems medicine approaches to cancer treatment, developing the DrugLogics pipeline for drug synergy prediction. Work combines logical modeling of signaling networks with high-throughput drug screening in patient-derived cells.

Publications demonstrate consistent focus on computational oncology, with themes including:

• Boolean network modeling of drug interactions
• High-throughput combination screening platforms
• Nanotechnology applications in drug delivery

Awards and Honors:

• Medical Teaching Award, Norwegian Medical Association (2024)
• Lecturer of the Year, NTNU Medical Students (2019, 2023)

Current projects include:

• PRESORT (RCN-funded drug response prediction)
• OncoLogics (EU PerMed consortium)
• COLOGIC (3D patient-derived tumor models)

Lab comprises 5 PhD candidates and postdoctoral researchers investigating precision oncology approaches.